Audion Therapeutics is a startup based in the Netherlands.
Based in the Netherlands, Audion Therapeutics is a startup.
Audion Therapeutics BV is a clinical-stage biotechnology company developing drug therapies to treat acquired sensorineural hearing loss by targeting the gamma-secretase protein complex; its lead candidate (LY3056480) has been administered intratympanically and evaluated in Phase I/IIa studies. The company focuses on small-molecule gamma-secretase inhibitors to restore cochlear hair cell function and improve hearing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.